Literature DB >> 4197635

Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals.

H F Hardman, C O Haavik, M H Seevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197635     DOI： 10.1016/s0041-008x(73)80016-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  18 in total

Review 1.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

2.  Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.

Authors:  R D Crean; S A Davis; S N Von Huben; C C Lay; S N Katner; M A Taffe
Journal:  Neuroscience       Date:  2006-07-28       Impact factor: 3.590

Review 3.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

4.  Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques.

Authors:  Stefani N Von Huben; Christopher C Lay; Rebecca D Crean; Sophia A Davis; Simon N Katner; Michael A Taffe
Journal:  Neuropsychopharmacology       Date:  2006-04-12       Impact factor: 7.853

5.  MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.

Authors:  Eugene A Kiyatkin; Suelynn E Ren
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 6.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 7.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

8.  Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.

Authors:  Eugene A Kiyatkin; Suelynn Ren; Ken T Wakabayashi; Michael H Baumann; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

9.  Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.

Authors:  Daniel Coman; Basavaraju G Sanganahalli; Lihong Jiang; Fahmeed Hyder; Kevin L Behar
Journal:  NMR Biomed       Date:  2015-08-19       Impact factor: 4.044

10.  Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose.

Authors:  Tomás Pálenícek; Marie Balíková; Vera Bubeníková-Valesová; Jirí Horácek
Journal:  Psychopharmacology (Berl)       Date:  2007-10-07       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.